HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Moderate Fuchs' endothelial dystrophy ATPase pump site density.

Abstract
The Na+, K+-ATPase pump site density on corneal endothelial cells from Fuchs' endothelial dystrophy corneas has been shown to be drastically decreased in end-stage disease (McCartney et al, Invest Ophthalmol Vis Sci 28:1955, 1987) and significantly increased in the early stages (Geroski et al, Ophthalmology 92:759, 1985) as compared to normal endothelium. In order to provide values for corneas between these two extremes, eye bank corneas from donors with no evidence of corneal edema but with guttata across the extent of the cornea were processed for autoradiography as well as immunohistochemistry. Pump site density was increased compared to end-stage disease but was less than values reported for either functional tissue or early stage disease. Similarly, immunohistochemistry results showed the amount of Na+, K+-ATPase antibody localization to be increased in respect to end-stage disease, but reduced as compared to functional tissue. These results suggest that pump site density on endothelial cells affected with Fuchs' endothelial dystrophy follows a gradual decline towards end-stage disease values as opposed to a sudden sharp deterioration after an initial increase.
AuthorsM D McCartney, T O Wood, B J McLaughlin
JournalInvestigative ophthalmology & visual science (Invest Ophthalmol Vis Sci) Vol. 30 Issue 7 Pg. 1560-4 (Jul 1989) ISSN: 0146-0404 [Print] United States
PMID2545644 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Fixatives
  • Ouabain
  • Sodium-Potassium-Exchanging ATPase
Topics
  • Aged
  • Autoradiography
  • Corneal Dystrophies, Hereditary (pathology)
  • Epithelium
  • Female
  • Fixatives
  • Fuchs' Endothelial Dystrophy (immunology, pathology)
  • Humans
  • Immunologic Techniques
  • Ouabain (metabolism)
  • Sodium-Potassium-Exchanging ATPase (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: